Precision Optics (POCI)

Executive Summary

Precision Optics Corporation (POCI) is a niche designer and manufacturer of micro-optical components and imaging systems, specializing in ultra-small lenses, prisms, and CMOS endoscopes as small as 0.6mm in diameter. Founded in 1982 and headquartered in Gardner, Massachusetts, the company serves medical, defense, and industrial markets, with a strong focus on enabling minimally invasive surgical procedures. Its vertically integrated capabilities from design to manufacturing position it as a key supplier to OEMs in ophthalmology and other surgical specialties. With a market cap of approximately $50 million, Precision Optics is a small-cap player with significant intellectual property and a long history of innovation. Growth prospects hinge on increasing adoption of minimally invasive surgery and miniaturization trends in defense and industrial imaging. The company's recent development of next-generation endoscopes and micro-optics positions it for potential FDA clearances and new OEM contracts. However, execution risks remain given its small scale and reliance on a few large customers. If successful, Precision Optics could benefit from secular tailwinds in medical device miniaturization, but near-term revenue visibility is limited. The company's stock is thinly traded and may be subject to volatility.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for next-gen 0.6mm CMOS endoscope70% success
• Q2 2026Major OEM contract award for defense/aerospace micro-optics60% success
• Q4 2026Launch of new industrial micro-optics product line for machine vision50% success